A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites
NCT06415500
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
9
Enrollment
OTHER_GOV
Sponsor class
Conditions
Gynecologic Cancer
Interventions
DRUG:
NK042
Sponsor
Anhui Provincial Hospital